Altimmune IncAdd to My Watchlist

ALT:USNASDAQ GMIndustry: Medical-Drugs
  • 2.66
  • 0.00  0.00%
    Today's Change
  • 2.66
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 10/20/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding16 million
Market Cap$41 million
Return on Equity ttm858.98%
Last Dividend$29.10
Dividend Yield ttm1093.98
Relative Dividend Yield benchmark--
Dividend Ex-Date2/6/17
Dividend Pay Date2/3/17
EPS: Year Actual ttm7.452
EPS: Year Est. 12/17 ttm-0.720
EPS: Quarterly Actual -- -0.26
EPS: Quarterly Est. 9/17 -0.23
Price/Earnings ttm0.36
Relative Price/Earnings0.016
Earnings Growth Rate--
Company Description
Altimmune, Inc. operates as a clinical stage immunotherapeutic biotechnology company. The Company discovers and develops novel products that engage, stimulate, and improve immune responses for the prevention and treatment of acute respiratory and chronic viral infections and cancer. Altimmune serves patients worldwide.
Revenue$5 million
Net Income$194 million
Total Assets$225 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!